CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
{{output}}
Background: Calcitonin gene-related peptide (CGRP) (receptor) antibodies (erenumab, fremanezumab and galcanezumab) are increasingly used in prophylactic treatment of migraine. In the approval studies, severely affected patients w... ...
